COVID-19 outcomes in patients with and without autoimmune rheumatic diseases: A multicenter comparative study.

Nasser K Abdulnaby Sherif Mohamed Gamal Alkhateeb Alkemary Marwa Abdo Irene M Sabry Mohamed I Belita Sally S Mohamed

Published in: International journal of rheumatic diseases (2023)

AIRD may not affect COVID-19 severity and outcome. Similarly, immunosuppressive medications had no effect; except that patients on systemic steroids had longer duration for recovery. Comorbid conditions, such as hypertension, may be associated with more severe COVID-19 disease course.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
blood pressure
chronic kidney disease
respiratory syndrome coronavirus
multiple sclerosis
peritoneal dialysis
prognostic factors
drug induced
early onset
clinical trial
cross sectional
adipose tissue
weight loss
glycemic control